Mantra Pharma Inc recorded insider trading activity on July 21, 2025, when Director Raj Chowdhry purchased 300,000 shares valued at $30,000. Previous acquisitions by Rajinder Chowdhry occurred during 2022. These historical transactions represent the most recent documented equity movements by company leadership.